151 related articles for article (PubMed ID: 19232278)
1. Functional heartburn: what it is and how to treat it.
Fass R
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):23-33, v. PubMed ID: 19232278
[TBL] [Abstract][Full Text] [Related]
2. Persistent heartburn in a patient on proton-pump inhibitor.
Fass R
Clin Gastroenterol Hepatol; 2008 Apr; 6(4):393-400. PubMed ID: 18387497
[No Abstract] [Full Text] [Related]
3. Upper GI tract findings in patients with heartburn in whom proton pump inhibitor treatment failed versus those not receiving antireflux treatment.
Poh CH; Gasiorowska A; Navarro-Rodriguez T; Willis MR; Hargadon D; Noelck N; Mohler J; Wendel CS; Fass R
Gastrointest Endosc; 2010 Jan; 71(1):28-34. PubMed ID: 19922918
[TBL] [Abstract][Full Text] [Related]
4. Management of heartburn not responding to proton pump inhibitors.
Fass R; Sifrim D
Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
[TBL] [Abstract][Full Text] [Related]
5. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
[TBL] [Abstract][Full Text] [Related]
6. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
7. Association between baseline impedance values and response proton pump inhibitors in patients with heartburn.
de Bortoli N; Martinucci I; Savarino E; Tutuian R; Frazzoni M; Piaggi P; Bertani L; Furnari M; Franchi R; Russo S; Bellini M; Savarino V; Marchi S
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1082-8.e1. PubMed ID: 25499991
[TBL] [Abstract][Full Text] [Related]
8. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment and characterization of visceral hyperalgesia evoked by esophageal balloon distention and acid perfusion in patients with functional heartburn, nonerosive reflux disease, and erosive esophagitis.
Yang M; Li ZS; Chen DF; Zou DW; Xu XR; Fang DC; Xu GM; Stephens RL; Wang ZG
Clin J Pain; 2010 May; 26(4):326-31. PubMed ID: 20393268
[TBL] [Abstract][Full Text] [Related]
10. Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responders to proton pump inhibitors.
Ribolsi M; Emerenziani S; Petitti T; Addarii MC; Balestrieri P; Cicala M
Dig Liver Dis; 2012 Jul; 44(7):549-54. PubMed ID: 22366345
[TBL] [Abstract][Full Text] [Related]
11. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
[TBL] [Abstract][Full Text] [Related]
12. Functional heartburn and non-erosive reflux disease.
Savarino V; Savarino E; Parodi A; Dulbecco P
Dig Dis; 2007; 25(3):172-4. PubMed ID: 17827934
[TBL] [Abstract][Full Text] [Related]
13. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
[TBL] [Abstract][Full Text] [Related]
14. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
[TBL] [Abstract][Full Text] [Related]
15. Functional heartburn: the stimulus, the pain, and the brain.
Fass R; Tougas G
Gut; 2002 Dec; 51(6):885-92. PubMed ID: 12427796
[TBL] [Abstract][Full Text] [Related]
16. Nighttime heartburn in patients with gastroesophageal reflux disease under routine care.
Nocon M; Labenz J; Jaspersen D; Leodolter A; Meyer-Sabellek W; Stolte M; Vieth M; Lind T; Malfertheiner P; Willich SN
Digestion; 2008; 77(2):69-72. PubMed ID: 18349541
[TBL] [Abstract][Full Text] [Related]
17. [Non-erosive gastroesophageal reflux disease. Incidence of clinical forms, characteristics of esophageal exposure to acid and symptomatic correlations].
Soto Pérez JC; Icaza ME; Vargas F; Valdovinos Díaz MA
Rev Gastroenterol Mex; 2003; 68(2):113-9. PubMed ID: 15127647
[TBL] [Abstract][Full Text] [Related]
18. [Dyspepsia and heartburn in primary care: a rational and economic approach].
Labenz J
MMW Fortschr Med; 2009 Aug; 151(34-35):47-8. PubMed ID: 19771792
[No Abstract] [Full Text] [Related]
19. Gastroesophageal reflux disease-related and functional heartburn: pathophysiology and treatment.
Miwa H; Kondo T; Oshima T
Curr Opin Gastroenterol; 2016 Jul; 32(4):344-52. PubMed ID: 27206157
[TBL] [Abstract][Full Text] [Related]
20. Effect of tegaserod on esophageal pain threshold, regurgitation, and symptom relief in patients with functional heartburn and mechanical sensitivity.
Rodriguez-Stanley S; Zubaidi S; Proskin HM; Kralstein JR; Shetzline MA; Miner PB
Clin Gastroenterol Hepatol; 2006 Apr; 4(4):442-50. PubMed ID: 16616348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
